BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

601 related articles for article (PubMed ID: 9049522)

  • 1. Coronary vasodilator reserve in primary and secondary left ventricular hypertrophy. A study with positron emission tomography.
    Choudhury L; Rosen SD; Patel D; Nihoyannopoulos P; Camici PG
    Eur Heart J; 1997 Jan; 18(1):108-16. PubMed ID: 9049522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: a study with nitrogen-13 ammonia and positron emission tomography.
    Camici P; Chiriatti G; Lorenzoni R; Bellina RC; Gistri R; Italiani G; Parodi O; Salvadori PA; Nista N; Papi L
    J Am Coll Cardiol; 1991 Mar; 17(4):879-86. PubMed ID: 1999624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syncope and ventricular arrhythmias in hypertrophic cardiomyopathy are not related to the derangement of coronary microvascular function.
    Lorenzoni R; Gistri R; Cecchi F; Olivotto I; Chiriatti G; Elliott P; McKenna WJ; Camici PG
    Eur Heart J; 1997 Dec; 18(12):1946-50. PubMed ID: 9447323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET/CT assessment of symptomatic individuals with obstructive and nonobstructive hypertrophic cardiomyopathy.
    Bravo PE; Pinheiro A; Higuchi T; Rischpler C; Merrill J; Santaularia-Tomas M; Abraham MR; Wahl RL; Abraham TP; Bengel FM
    J Nucl Med; 2012 Mar; 53(3):407-14. PubMed ID: 22315440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial beta adrenoceptor density in primary and secondary left ventricular hypertrophy.
    Choudhury L; Rosen SD; Lefroy DC; Nihoyannopoulos P; Oakley CM; Camici PG
    Eur Heart J; 1996 Nov; 17(11):1703-9. PubMed ID: 8922919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures.
    Cannon RO; Rosing DR; Maron BJ; Leon MB; Bonow RO; Watson RM; Epstein SE
    Circulation; 1985 Feb; 71(2):234-43. PubMed ID: 4038383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early impairment of coronary flow reserve in young men with borderline hypertension.
    Laine H; Raitakari OT; Niinikoski H; Pitkänen OP; Iida H; Viikari J; Nuutila P; Knuuti J
    J Am Coll Cardiol; 1998 Jul; 32(1):147-53. PubMed ID: 9669263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homogeneously reduced versus regionally impaired myocardial blood flow in hypertensive patients: two different patterns of myocardial perfusion associated with degree of hypertrophy.
    Gimelli A; Schneider-Eicke J; Neglia D; Sambuceti G; Giorgetti A; Bigalli G; Parodi G; Pedrinelli R; Parodi O
    J Am Coll Cardiol; 1998 Feb; 31(2):366-73. PubMed ID: 9462581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a systemic defect of resistance-sized arterioles in hypertrophic cardiomyopathy.
    Pedrinelli R; Spessot M; Chiriatti G; Gistri R; Salvadori P; Catapano G; Panarace G; Papi L; L'Abbate A; Camici PG
    Coron Artery Dis; 1993 Jan; 4(1):67-72. PubMed ID: 8269185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary vasodilatory capacity is impaired in patients with dilated cardiomyopathy.
    Weismüller S; Czernin J; Sun KT; Fung C; Phelps ME; Schelbert HR
    Am J Card Imaging; 1996 Jul; 10(3):154-62. PubMed ID: 8914701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy.
    Cecchi F; Olivotto I; Gistri R; Lorenzoni R; Chiriatti G; Camici PG
    N Engl J Med; 2003 Sep; 349(11):1027-35. PubMed ID: 12968086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison and effectiveness of regadenoson versus dipyridamole on stress electrocardiographic changes during positron emission tomography evaluation of patients with hypertrophic cardiomyopathy.
    Bravo PE; Pozios I; Pinheiro A; Merrill J; Tsui BM; Wahl RL; Bengel FM; Abraham MR; Abraham TP
    Am J Cardiol; 2012 Oct; 110(7):1033-9. PubMed ID: 22748357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of verapamil on absolute myocardial blood flow in hypertrophic cardiomyopathy.
    Gistri R; Cecchi F; Choudhury L; Montereggi A; Sorace O; Salvadori PA; Camici PG
    Am J Cardiol; 1994 Aug; 74(4):363-8. PubMed ID: 8059699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertrophic cardiomyopathy: MR measurement of coronary blood flow and vasodilator flow reserve in patients and healthy subjects.
    Kawada N; Sakuma H; Yamakado T; Takeda K; Isaka N; Nakano T; Higgins CB
    Radiology; 1999 Apr; 211(1):129-35. PubMed ID: 10189462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary vasodilator reserve is impaired in patients with hypertrophic cardiomyopathy and left ventricular dysfunction.
    Lorenzoni R; Gistri R; Cecchi F; Olivotto I; Chiriatti G; Elliott P; McKenna WJ; Camici PG
    Am Heart J; 1998 Dec; 136(6):972-81. PubMed ID: 9842009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dipyridamole-echocardiography and thallium exercise myocardial scintigraphy in the diagnosis of obstructive coronary or microvascular disease in hypertensive patients with left ventricular hypertrophy and angina].
    Astarita C; Nicolai E; Liguori E; Gambardella S; Rumolo S; Maresca FS
    G Ital Cardiol; 1998 Sep; 28(9):996-1004. PubMed ID: 9788038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial blood flow and efficiency in concentric and eccentric left ventricular hypertrophy.
    Akinboboye OO; Chou RL; Bergmann SR
    Am J Hypertens; 2004 May; 17(5 Pt 1):433-8. PubMed ID: 15110903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary flow reserve in severe aortic valve stenosis: a positron emission tomography study.
    Carpeggiani C; Neglia D; Paradossi U; Pratali L; Glauber M; L'Abbate A
    J Cardiovasc Med (Hagerstown); 2008 Sep; 9(9):893-8. PubMed ID: 18695425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of age and hemodynamics on myocardial blood flow and flow reserve.
    Czernin J; Müller P; Chan S; Brunken RC; Porenta G; Krivokapich J; Chen K; Chan A; Phelps ME; Schelbert HR
    Circulation; 1993 Jul; 88(1):62-9. PubMed ID: 8319357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positron emission tomographic evaluation of regulation of myocardial perfusion in physiological (elite athletes) and pathological (systemic hypertension) left ventricular hypertrophy.
    Kjaer A; Meyer C; Wachtell K; Olsen MH; Ibsen H; Opie L; Holm S; Hesse B
    Am J Cardiol; 2005 Dec; 96(12):1692-8. PubMed ID: 16360359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.